Abstract
The kidneys and the liver are the principal organs for the inactivation of circulating organic cations. Recently, an organic cation transporter (OCT1) has been cloned from rat kidney. In order to answer the question whether OCT1 is involved also in hepatic uptake of organic cations, the pharmacological characteristics of organic cation transport in hepatocytes were compared to the characteristics of transiently expressed OCT1.
Primary cultures of rat hepatocytes avidly accumulated the small organic cation 3H-1-methyl-4-phenylpyridinium (3H-MPP+). At equilibrium, the hepatocytes accumulated 3H-MPP+ 56-fold. Initial rates of specific 3H-MPP+ transport in hepatocytes were saturable. The half-saturating concentration was 13 μmol/l. 3H-MPP+ transport was sensitive to quinine (Ki = 0.79 μmol/l) and cyanine863 (Ki = 0.097 µmol/l). Quinine and cyanine863 are known inhibitors of type I hepatic transport of cationic drugs and of renal excretion of organic cations, respectively. To compare the functional characteristics of 3H-MPP+ transport in hepatocytes with those of OCT1, OCT1 has been heterologously expressed and characterized in a mammalian cell line (293 cells). Initial rates of 3H-MPP+ transport were saturable, the Km being 13 μmol/l. The rank order of inhibitory potencies of various inhibitors was almost identical in hepatocytes and 293 cells transiently transfected with OCT1. There was a positive correlation between the Ki's for the inhibition of 3H-MPP+ transport in isolated hepatocytes and transfected 293 cells (r = 0.85; P<0.01; n = 8).
The results indicate that OCT1 is functionally expressed not only in the kidney but also in hepatocytes where it is responsible for the transport of small organic cations which, in the past, have been classified as type I substrates.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cheng Y-C, Prusoff W (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Di Monte D, Ekstrom G, Shinka T, Smith M, Trevor A, Castagnoli Jr N (1987) Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes. Chem Biol Interact 62:105–116
Eaton D, Klaassen C (1978) Carrier-mediated transport of the organic cation procaine amide ethobromide by isolated rat liver parenchymal cells. J Pharmacol Exp Ther 206:595–606
Graham F, Smiley J, Russell W, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenoviuus type 5. J Gen Virol 36:59–72
Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549–552
Klaassen C, Watkins III J (1984) Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev 36:1–67
Lowry O, Rosenbrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
MacGregor G, Caskey C (1989) Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucl Acids Res 17:2365
Martel F, Azevedo I, Osswald W (1993) Uptake and metabolism of 3H-adrenaline and 3H-noradrenaline by isolated hepatocytes and liver slices of the rat. Naunyn-Schrnuedeberg's Arch Pharmacol 348:350–357
Meijer D (1989) Transport and metabolism in the hepatobiliary system. In: Schulz S, Forte J, Rauner BB (eds) The gastrointestinal system, vol 3. University Press, Oxford, pp 717–758
Meijer D, Mol W, Müller M, Kurz G (1990) Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations. J Pharmacokinet Biopharm 18:35–70
Mol W, Müller M, Kurz G, Meijer D (1992) Investigations on the hepatic uptake systems for organic cations with a photoaffinity probe of procainamide ethobromide. Biochem Pharmacol 43: 2217–2226
Moseley R, Jarose M, Permoad P (1992) Organic cation transport by rat liver plasma membrane vesicles: studies with tetraethylammonium. Am J Physiol 263:G775-G785
Moseley R, Smit H, van Solkema B, Wang W, Meijer D (1994) Mechanisms for the hepatic uptake and biliary excretion of cationic drugs. Hepatology 20:261A
Moseley R, Smut H, van Solkema B, Wang W, Meijer D (1996) Mechanisms for the hepatic uptake and biliary excretion of tributylmethylammonium: studies with rat liver plasma membrane vesicles. J Pharmacol Exp Ther 276:561–567
Nakamura H, Sano H, Yamazaki M, Sugiyama Y (1994) Carrier-mediated transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system. J Pharmacol Exp Ther 269:1220–1227
Oude Elferink R, Meijer D, Kuipers F, Jansen P, Groen A, Groothuis G (1995) Hepatobiliary secretion of organic compounds; molecular mechanism of membrane transport. Biochim Biophys Acta 1241:215–268
Rennick B (1981) Renal tubule transport of organic cations. Am J Physiol 240:F83-F89
Rennick B, Kandel A, Peters L (1956) Inhibition of the renal tubular excretion of tetraethylammonium and N′-methylnicotinamide by basic cyanune dyes. J Pharmacol Exp Ther 118:204–219
Russ H, Engel W, Schömig E (1993a) Isocyanines and pseudoisocyanines as a novel class of potent noradrenaline transport inhibitors: synthesis, detection and biological activity. J Med Chem 36:4208–4214
Russ H, Sonna J, Keppler K, Baunach S, Schömig E (1993b) Cyanine-related compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport. Naunyn-Schmiedeberg's Arch Pharmacol 348:458–465
Russ H, Staudt K, Gliese M, Schömig E (1994) The extraneuronal monoamine transporter exists in the central nervous system. Can J Physiol Pharmacol 72:324
Russ H, Staudt K, Martel F, Gliese M, Schömig E (1996) The extraneuronal transporter for monoarnune transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 8:1256–1264
Schömig E, Babin-Ebell J, Russ H (1993) 1,1′-Diethyl-2,2′-cyanine (decynium22) potently inhibits the renal transport of organic cations. Naunyn-Schmiedeberg's Arch Pharmacol 347:379–383
Schömig E, Schönfeld C-L (1990) Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells). Naunyn-Schmiedeberg's Arch Pharmacol 341:404–410
Segel I (1975) Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme systems. John Wiley, New York London Sydney Toronto
Singh Y, Swanson E, Sokoloski E, Kutty R, Krishna G (1988) MPTP and MPTP analogs induce cell death in cultured rat hepatocytes involving the formation of pyridinium metabolites. Toxicol Appl Pharmacol 96:347–359
Staudt K, Russ H, Gliese M, Schömig E (1993) The extraneuronal noradrenaline carrier (uptake2) exists in the human central nervous system (CNS). Naunyn-Schmiedeberg's Arch Pharmacol 347:R118
Streich S, Brüss M, Bönisch H (1996) Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells. Naunyn-Schmiedeberg's Arch Pharmacol 353:328–333
Takano M, Inui K-I, Okano T, Saito H, Hori R (1984) Carrier-mediated transport systems of tetraethylammonium in rat renal brush-border and basolateral membrane vesicles. Biochim Biophys Acta 773:113–124
Trendelenburg U (1988) The extraneuronal uptake and metabolism of catecholamines. In: Trendelenburg U, Weiner N (eds) Catecholamines I, vol 90. Springer, Berlin Heidelberg New York London Tokyo, pp 279–319
Ullrich K, Rumrich G, David C, Fritzsch G (1993) Bisubstrates: substances that interact with renal contraluminal organic anion and organic cation transport systems. I. Amines, piperidines, piperazines, azepines, pyridines, quinolines, imidazoles, thiazoles, guanidines and hydrazines. Eur J Physiol 425:280–299
Wilkinson L (1989) SYSTAT: the system for statistics. SYSTAT Inc., Evanston, Ill, USA
Wright S, Wunz T (1987) Transport of tetraethylammonium by rabbit renal brush-border and basolateral membrane vesicles. Am J Physiol 253:F1040-F1050
Xie M, Cochran M, Lidofsky S, Scharschmidt B (1992) A 1.8–3 kB mRNA encodes for a hepatic organic cation transport protein. Hepatology 16 [Suppl]:147A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martel, F., Vetter, T., Russ, H. et al. Transport of small organic cations in the rat liver. Naunyn-Schmiedeberg's Arch Pharmacol 354, 320–326 (1996). https://doi.org/10.1007/BF00171063
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00171063